Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$348,131,852
New position
Shares Held
2,221,362
first reported quarter
Ownership
0.117%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#14
of 1,596 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 93%
None 7%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jupiter Topco LLC holds $12,282,643,091 across 14 Drug Manufacturers - General names. NVS ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,891,118 | $4,667,124,049 | |
| 2 | AZN |
Astrazeneca PLC
|
11,866,013 | $2,250,033,383 | |
| 3 | JNJ |
Johnson & Johnson
|
7,746,487 | $1,967,375,301 | |
| 4 | ABBV |
AbbVie Inc.
|
6,201,973 | $1,560,664,483 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,901,539 | $501,347,761 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,546,841 | $448,107,890 | |
| 7 | NVS |
Novartis AG
This page
|
2,221,362 | $348,131,852 | |
| 8 | AMGN |
Amgen Inc
|
893,898 | $323,698,342 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $348,131,852 | 2,221,362 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||